Novozymes extends the lifetime of textiles with sustainable innovation
Consumer and regulatory demands for more sustainable clothing and textiles are growing and the fashion industry is rising to the challenge.Now Novozymes offers biopolishing for manmade cellulosic fibers (MMCF) including viscose, modal and lyocell. This helps enhance the quality of fabrics, making them look new for longer and extending their lifespan.
COPENHAGEN, DENMARK – June 7, 2022 – MMCF is the third most used textile fiber in the world after polyester and cotton. Yet it lags behind polyester and cotton with a market share of around 6 percent, mainly caused by quality issues such as the fabrics developing fuzz and pills after only a few washes. This makes the garments look worn and impact consumers’ perception of quality and sustainability.
With Fiberlife® Novozymes offers a world-first family of biopolishing that minimizes fuzz and pilling in viscose, modal and lyocell. Biopolishing uses enzymes to remove loose fiber ends, leaving a clean, new-looking surface, which lasts for at least 60 washes. It can also improve print quality in daily wash and wear.
- “$1With Fiberlife®, MMCF fabrics are given the wash and wear durability that consumers demand, prolonging the time the garments look and feel new. This is a better solution for the fashion and broader textile industry, consumers, and the planet,” says Dina Lipp, Global Marketing Manager at Novozymes.
Biopolishing for increased circularity
Circular fashion starts with sustainable production, free from waste, water pollution, emissions, and chemicals. Novozymes’ biodegradable enzymes support this by reducing the use of water and chemicals in the production.
- “At Novozymes, we want to create forward-thinking solutions for the textile and fashion industry. That is why we have been working intensively on making MMCF biopolishing possible for viscose, modal and lyocell. We see a big potential for textile manufacturers to extend the longevity of MMCF fabrics, ultimately offering consumers longer lasting garments made of fibers from nature,” says Pedro E. G. Loureiro, Global Business Development Manager at Novozymes.
Buying clothes that last longer is central to minimizing the environmental impact of the fashion industry. Fiberlife® can help textile producers improve on quality and sustainability while strengthening the connection towards a growing number of eco-conscious consumers.
The global nonprofit Textile Exchange is the driving force behind climate action on textile fiber and materials in the textile industry. Its new Climate+ Strategy aims to guide the fashion and textile industry towards CO2 reductions of 45% by 2030 while reducing water consumption.
MMCF fibers are sourced and produced mainly from renewable wood and can support the shift from oil-derived synthetic fibers. By extending the quality and lifespan of MMFC textiles, Fiberlife® can help the fashion industry to further reduce its environmental footprint.
How biopolishing works:
- Biopolishing is an environmentally friendly process that uses enzymes to extend the lifetime of cotton, viscose, modal and lyocell.
- Biopolishing uses enzymes to remove excess fibers from the fabric, leaving a clean surface.
This improves dyeability and creates longer lasting textiles.
- The microfibrils that protrude from cellulose-based fibers are microscopic hairs from the fibers of these fabrics. They lead to fuzz and pilling, which makes the fabric surface feel rough and trap dirt to reduce cleanness. Both the trapped dirt and the microfibrils themselves make colors and whites look less bright.
- Textile mills polish cellulose-based fabrics before, during or after dyeing.
Learn more about Fiberlife®: https://biosolutions.novozymes.com/en/textiles/campaigns/unlock-quality-and-innovation
Experience our full range of enzymes for biopolishing:
Novozymes is the world leader in biological solutions. Together with customers, partners, and the global community, we improve industrial performance while preserving the planet's resources and helping build better lives. As the world's largest provider of enzyme and microbial technologies, our bioinnovation enables higher agricultural yields, low-temperature washing, energy-efficient production, renewable fuel, and many other benefits that we rely on today and in the future.
We call it Rethink Tomorrow. www.novozymes.com
NASDAQ OMX: NZYM-B • 6,200 employees • DKK 14,5 billion turnover • 30+ industries • 700+ products
Novozymes Media Relations
Senior Media Relations Manager
+45 3077 1534
- Novozymes extends the lifetime of textiles with sustainable innovation
- Non-polished vs biopolished fabric
To view this piece of content from ml-eu.globenewswire.com, please give your consent at the top of this page.
About GlobeNewswire by notified
One Liberty Plaza - 165 Broadway
NY 10006 New York
GlobeNewswire by notified is one of the world's largest newswire distribution networks, specializing in the delivery of corporate press releases financial disclosures and multimedia content to the media, investment community, individual investors and the general public.
Subscribe to releases from GlobeNewswire by notified
Subscribe to all the latest releases from GlobeNewswire by notified by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from GlobeNewswire by notified
Cloudbeds Acquires Whistle, Moves to Solve Friction in Guest Journey27.6.2022 14:00:00 CEST | Press release
No. 1 PMS and No. 1 guest messaging platform join forces to integrate guest engagement solutions seamlessly into day-to-day lodging business operations SAN DIEGO, June 27, 2022 (GLOBE NEWSWIRE) -- Cloudbeds, the hospitality management platform powering more reservations and happier guests for lodging businesses around the globe, announced today at HITEC 2022 the acquisition of the industry’s leading guest engagement solution, Whistle. Together, the companies will integrate their best-in-class technologies to remove friction points in the guest journey through a single platform. “The term contactless is becoming far too synonymous with hospitality,” said Richard Castle, COO and Co-Founder of Cloudbeds. “We want more contact between lodging businesses and their guests to create purposeful touchpoints, answer questions and provide guidance through the entire guest journey. Research shows that engaged guests spend more, leave better reviews and the majority prefer to communicate via digita
Arcoma vinner viktig upphandling i Finland. (MAR)27.6.2022 13:00:00 CEST | Pressemelding
2022-06-27 PRESSRELEASE Arcoma vinner viktig upphandling i Finland. Arcoma AB har vunnit viktig upphandlingpå upp till 6Arcoma Precision i5-system till ”HUS Medical Imaging Center” i Finland.Tre av systemen kommer att installeras under 2022 och kontraktet har en option på ytterligare tre system för installation under 2023. Det totala ordervärdet är upp till cirka 7,5MSek, beroende på tillval och optioner. Upphandlingen är vunnen av Lifemed Medical Systems som är Arcomas distributör och samarbetspartner i Finland och slutkunden är ”HUS Medical Imaging Center” som är en del av Helsingfors universitetssjukhus. "Vi är mycket glada över denna möjlighet att leverera dessa system till HUS, tillsammans med vår partner Arcoma. Ergonomi, patientsäkerhet och bra bildkvalitet var nyckelfaktorerna i detta anbud och Precision i5 är en perfekt lösning för att möta dessa behov ”, säger Mikko Isoviita, Sales Manager Lifemed Medical Systems. "Det är mycket glädjande att vi genom Lifemed vunnit denna upp
Arcoma wins important procurement in Finland. (MAR)27.6.2022 13:00:00 CEST | Press release
2022-06-27 PRESSRELEASE Arcoma wins important procurement in Finland. Arcoma AB has won important procurement of up to 6 Arcoma Precision i5 systems to “HUS Medical Imaging Center” in Finland. Three of the systems will be installed in 2022 and the contract has an option for three more systems for installation in 2023. The total order value is up to approximately SEK 7.5 million, depending on options. The procurement was won by Lifemed Medical Systems, which is Arcoma's distributor and partner in Finland, and the end customer is the “HUS Medical Imaging Center”, which is part of Helsinki University Hospital. "We are very pleased for this opportunity to supply these systems to HUS, together with our long-term partner Arcoma. Ergonomics, patient safety and good image quality were they key factors in this tender and Precision i5 is a perfect solution to address these needs”, says Mikko Isoviita, Sales Manager Lifemed Medical Systems. "It is great that we through Lifemed have won this procu
Change in Aspo’s Group Executive Committee27.6.2022 10:20:00 CEST | Press release
Aspo Plc Stock exchange release June 27, 2022 at 11:20 a.m. Change in Aspo’s Group Executive Committee Heli Arantola, Managing Director of Aspo’s subsidiary Leipurin, has resigned to join another company. Arantola will leave the company in December at the latest, and the process of selecting her successor has begun. “I thank Heli for her excellent contribution to the modernization of Leipurin and transforming the company in the rapidly changing bakery and food industry. I wish her the best of luck in her future endeavors,” says Rolf Jansson, CEO of Aspo Group. Aspo Plc Rolf Jansson CEO Further information, please contact: Rolf Jansson, CEO, Aspo Plc, +358 400 600 264, firstname.lastname@example.org DISTRIBUTION: Nasdaq Helsinki Key media www.aspo.com Aspo creates value by owning and developing business operations sustainably and in the long term. Our companies aim to be market leaders in their sectors. They are responsible for their own operations, customer relationships and the development of
Cool Company Ltd. – Mandatory Notification Of Trade27.6.2022 10:17:48 CEST | Press release
EPS Ventures Ltd., close associate of Cyril Ducau, Chair of the Board of Cool Company Ltd. (the “Company”), has on 24 June 2022 acquired 7,035 shares in the Company at a price of NOK 89.307527 per share. Following the transaction, EPS Ventures Ltd. holds a total of 15,598,523 shares in the Company, equivalent to 38.99% of the Company’s shares. Please see attached notification form in accordance with the Market Abuse Regulation article 19. This information is subject to the disclosure requirements pursuant to Section 5-12 the Norwegian Securities Trading Act Attachment Primary insider notification form